Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Healthcor Management Initiates Exposure to Oxygen Biotherapeutics, Inc. (OXBT)

Arthur Cohen and Joseph Healey‘s Healthcor Management has added Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) to its equity portfolio. The fund revealed holding 1.5 million shares of the company, the stake being equal to 5.39% of the outstanding stock.

Arthur B Cohen and Joseph Healey

Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT)s is a small cap healthcare company engaged in developing biotechnology products related to oxygen delivery to tissue. Its stock has gained around 24% since the beginning of the year. For the last quarter of 2013, the company reported a net loss of $0.86 per diluted share, narrowing the loss from $1.45 per share reported for the previous quarter. For 2014, analysts expect the company to deliver a net loss of -$0.87 per share.

Aside from Healthcor, another investor, that has started a stake in Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) recently, is Hal Mintz‘ Sabby Management. Sabby reported, earlier this month, holding more than 1.96 million shares of the company, which represent 7.43% of the outstanding stock. Ellington, managed by Mike Vranos, has also added the company to its equity portfolio during the last quarter of 2013, although it holds a less significant stake, which contains just 34,200 shares.

Earlier this year, Healthcor Management, reported boosting its position in another small-cap healthcare company, CareView Communications Inc (OTCBB:CRVW). In two filings, Healthcor disclosed raising its holding to 39.13 million shares, and then to 55.63 million, which represent 28.6% of the outstanding stock.

Healthcare stocks amass the largest portion of Healthcor’s $1.65 billion equity portfolio. The fund holds the largest position in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX): 10.00 million shares, worth $154.6 million. McKesson Corporation (NYSE:MCK) is the next largest holding, which has been raised by 250% over the quarter to 600,000 shares; followed by Cubist Pharmaceuticals Inc (NASDAQ:CBST), in which the fund owns 1.4 million shares.

Disclosure: none

Recommended Reading:

David Einhorn, Greenlight Capital Raise Stake in BioFuel Energy Corp. (BIOF); Send Business Proposal To Board

Wexford Capital Reveals New Position in Famous Dave’s of America, Inc.(DAVE)

Leon Cooperman is Bullish on London-listed Monitise Plc (MONI) and Raises Stake to 10.9%

 

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!